Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.67 |
| ▸ | CALCRL | Q16602 | 5/20 | 0.63 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.53 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31369283 | 0.86 | SLC6A2 (0.71) | SLC6A2CALCRLNMUR2NMUR1 | |
| SCHEMBL29845518 | 0.85 | REN (0.59) | SLC6A2 | |
| SCHEMBL30953188 | 0.85 | SLC6A2 (0.62) | SLC6A2CALCRL | |
| SCHEMBL8521204 | 0.84 | SLC6A2 (0.56) | SLC6A2CALCRLNMUR2NMUR1 | |
| SCHEMBL8441486 | 0.84 | KDM1A (0.54) | NMUR2NMUR1 | |
| SCHEMBL30123101 | 0.84 | SLC6A2 (0.68) | SLC6A2CALCRL | |
| SCHEMBL30953194 | 0.83 | SLC6A2 (0.65) | SLC6A2CALCRL | |
| SCHEMBL29488141 | 0.83 | SLC6A2 (0.73) | SLC6A2CALCRL | |
| SCHEMBL8441481 | 0.83 | NMUR2 (0.52) | SLC6A2CALCRLNMUR2NMUR1 | |
| SCHEMBL10787091 | 0.83 | SLC6A2 (0.62) | SLC6A2CALCRL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118286126-A | Dressing for treating facial or body surfaces | ELC 管理有限责任公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-3554470-B1 | COSMETIC COMPOSITIONS COMPRISING HYALURONIC ACID | ELC MAN LLC (US) | 2023-07-26 | — | — | EP | disclosed |
| CN-110381775-B | Packaging for skin treatment compositions and method of applying treatment compositions | ELC 管理有限责任公司 | 2022-11-01 | — | — | CN | disclosed |
| US-11291286-B2 | Cosmetic compositions with a micro-mesh structure | ELC MANAGEMENT LLC (US) | 2022-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11291286-B2 | Cosmetic compositions with a micro-mesh structure | CD44, CUTA, MSH6 | SLC6A2 2777/4885CALCRL 3983/4885NMUR2 1363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.